gc4419,cisplatin
galera therapeutics
['cisplatin', 'roman,(-romania)', 'galera thera']
this week, galera is attending the 2023 annual meeting in chicago where a prespecified analysis from our phase 3 roman trial on the effect of avasopasem on reducing cisplatin-related chronic kidney disease will be presented. #asco23 
Clinical-stage #biotech company transforming #radiotherapy for patients with #cancer